| scholarly article | Q13442814 |
| P50 | author | Yao-Zhong Xu | Q51136076 |
| Beatriz Montaner | Q55079979 | ||
| Catherine Harwood | Q62662925 | ||
| P2093 | author name string | Fumio Hanaoka | |
| Peter Karran | |||
| Susan L Walker | |||
| Xiaohong Zhang | |||
| Peter O'Donovan | |||
| Conal M Perrett | |||
| Jane M McGregor | |||
| P2860 | cites work | The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta | Q28115711 |
| Replication of damaged DNA in mammalian cells: new solutions to an old problem | Q30746296 | ||
| Defective global genome repair in XPC mice is associated with skin cancer susceptibility but not with sensitivity to UVB induced erythema and edema | Q32068354 | ||
| Photoactivation of DNA thiobases as a potential novel therapeutic option | Q34339210 | ||
| Repair and genetic consequences of endogenous DNA base damage in mammalian cells | Q34371854 | ||
| Pharmacogenetics and cancer therapy | Q34572110 | ||
| A role for ultraviolet A in solar mutagenesis | Q34589316 | ||
| Skin cancers after organ transplantation | Q35113533 | ||
| Oxidative damage to DNA: formation, measurement and biochemical features. | Q35592841 | ||
| Molecular basis of spontaneous mutation at the aprt locus of hamster cells | Q35597816 | ||
| Synthetic activity of Sso DNA polymerase Y1, an archaeal DinB-like DNA polymerase, is stimulated by processivity factors proliferating cell nuclear antigen and replication factor C. | Q38296309 | ||
| Peripheral blood mononuclear cell DNA 6-thioguanine metabolite levels correlate with decreased interferon-gamma production in patients with Crohn's disease on AZA therapy | Q40528442 | ||
| Spontaneous development of drug resistance: mismatch repair and p53 defects in resistance to cisplatin in human tumor cells | Q40865504 | ||
| Quantitation of 6-thioguanine residues in peripheral blood leukocyte DNA obtained from patients receiving 6-mercaptopurine-based maintenance therapy | Q41350084 | ||
| Incidence of skin cancer in 5356 patients following organ transplantation | Q42492822 | ||
| Non-melanoma skin cancer risk in the Queensland renal transplant population. | Q42527482 | ||
| Protection by ultraviolet A and B sunscreens against in situ dipyrimidine photolesions in human epidermis is comparable to protection against sunburn. | Q43504839 | ||
| Mechanisms of tolerance to DNA damaging therapeutic drugs | Q43829355 | ||
| Inherited variants of MYH associated with somatic G:C-->T:A mutations in colorectal tumors | Q43871566 | ||
| Fluorometric Assay of Thioguanine | Q45116704 | ||
| Replication of the base pair 6-thioguanine/5-methyl-2-pyrimidine with the large Klenow fragment of Escherichia coli DNA polymerase I. | Q52398963 | ||
| Photochemical sensitization by azathioprine and its metabolites--I. 6-Mercaptopurine | Q69499665 | ||
| Immunosuppression and risk of non-melanoma skin cancer in renal transplant recipients | Q73073923 | ||
| P433 | issue | 5742 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | DNA damage | Q5205747 |
| azathioprine | Q18939 | ||
| P304 | page(s) | 1871-4 | |
| P577 | publication date | 2005-09-16 | |
| P1433 | published in | Science | Q192864 |
| P1476 | title | Azathioprine and UVA light generate mutagenic oxidative DNA damage | |
| P478 | volume | 309 |
| Q50576898 | 2-Thiouracil intersystem crossing photodynamics studied by wavelength-dependent photoelectron and transient absorption spectroscopies. |
| Q37951744 | 4-Thiothymidine sensitization of DNA to UVA offers potential for a novel photochemotherapy |
| Q37171158 | 6-Thioguanine perturbs cytosine methylation at the CpG dinucleotide site by DNA methyltransferases in vitro and acts as a DNA demethylating agent in vivo |
| Q38693854 | A novel chalcone derivative S17 induces apoptosis through ROS dependent DR5 up-regulation in gastric cancer cells |
| Q38295916 | A practical guide to the use of thiopurines in oral medicine |
| Q42514247 | A surveillance model for skin cancer in organ transplant recipients: a 22-year prospective study in an ethnically diverse population |
| Q57399987 | An ab initio mechanism for efficient population of triplet states in cytotoxic sulfur substituted DNA bases: the case of 6-thioguanine |
| Q37447064 | Annotation of the Asian Citrus Psyllid Genome Reveals a Reduced Innate Immune System |
| Q37227694 | Association between Oxidative DNA Damage and Risk of Colorectal Cancer: Sensitive Determination of Urinary 8-Hydroxy-2'-deoxyguanosine by UPLC-MS/MS Analysis |
| Q36072486 | Associations between environmental factors and incidence of cutaneous melanoma. Review |
| Q38830835 | Azathioprine and Risk of Skin Cancer in Organ Transplant Recipients: Systematic Review and Meta-Analysis. |
| Q37164090 | Azathioprine prescribing in neurology |
| Q45289318 | Azathioprine treatment photosensitizes human skin to ultraviolet A radiation. |
| Q42447318 | Azathioprine-induced microsatellite instability is not observed in skin carcinomas of organ transplant recipients |
| Q39015006 | Basic aspects of the pathogenesis and prevention of non-melanoma skin cancer in solid organ transplant recipients: a review |
| Q26859216 | Burden of de novo malignancy in the liver transplant recipient |
| Q34520662 | Cancer Recurrence Following Immune-Suppressive Therapies in Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis |
| Q99237566 | Cancer Risk in Pediatric-Onset Inflammatory Bowel Disease |
| Q48102349 | Cancer in ANCA-Associated Glomerulonephritis: A Registry-Based Cohort Study. |
| Q87796374 | Cancer in Solid Organ Transplant Recipients: There Is Still Much to Learn and Do |
| Q54187954 | Cancer in liver transplant recipients: management and outcomes. |
| Q64236185 | Cardiovascular, antidepressant and immunosuppressive drug use in relation to risk of cutaneous melanoma: a protocol for a prospective case-control study |
| Q37417605 | Cellular and sub-cellular responses to UVA in relation to carcinogenesis |
| Q50966306 | Clinical and immunological features of very long-term survivors with a single renal transplant. |
| Q26765172 | Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society |
| Q37811514 | Clinical insights for cancer outcomes in renal transplant patients |
| Q42174784 | Clinical lessons to be learned from patients developing chronic myeloid leukemia while on immunosuppressive therapy after solid organ transplantation: yet another case after orthotopic heart transplantation. |
| Q37771531 | Clinical recommendations for the use of everolimus in heart transplantation |
| Q53078388 | Communication: the dark singlet state as a doorway state in the ultrafast and efficient intersystem crossing dynamics in 2-thiothymine and 2-thiouracil. |
| Q38892578 | Comparing Outcomes between Antibody Induction Therapies in Kidney Transplantation |
| Q47572480 | Comprehensive review of post-organ transplant hematologic cancers |
| Q33844623 | Crosslinking of DNA repair and replication proteins to DNA in cells treated with 6-thioguanine and UVA |
| Q40012751 | CsA can induce DNA double-strand breaks: implications for BMT regimens particularly for individuals with defective DNA repair |
| Q35032846 | Cyclosporine a mediates pathogenesis of aggressive cutaneous squamous cell carcinoma by augmenting epithelial-mesenchymal transition: role of TGFβ signaling pathway |
| Q91663760 | DNA Repair Footprint Uncovers Contribution of DNA Repair Mechanism to Mutational Signatures |
| Q42735492 | DNA breakage and cell cycle checkpoint abrogation induced by a therapeutic thiopurine and UVA radiation |
| Q38052129 | DNA damage and repair in human cancer: molecular mechanisms and contribution to therapy-related leukemias. |
| Q38938690 | DNA repair inhibition by UVA photoactivated fluoroquinolones and vemurafenib |
| Q46451323 | Decoding the Molecular Basis for the Population Mechanism of the Triplet Phototoxic Precursors in UVA Light-Activated Pyrimidine Anticancer Drugs. |
| Q45072650 | Dermatologist and gastroenterologist awareness of the potential of immunosuppressants used to treat inflammatory bowel disease to cause non-melanoma skin cancer |
| Q34815465 | Direct observation and quantitative characterization of singlet oxygen in aqueous solution upon UVA excitation of 6-thioguanines |
| Q41593052 | Discriminating patients with early-stage breast cancer from benign lesions by detection of oxidative DNA damage biomarker in urine |
| Q64111733 | Dissecting the Multiplicity of Immune Effects of Immunosuppressive Drugs to Better Predict the Risk of de novo Malignancies in Solid Organ Transplant Patients |
| Q38253832 | Does a personal or family history of malignancy preclude the use of immunomodulators and biologics in IBD. |
| Q38328785 | Does the nature of residual immune function explain the differential risk of non-melanoma skin cancer development in immunosuppressed organ transplant recipients? |
| Q28258977 | Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD |
| Q36662474 | Drug insight: maintenance immunosuppression in kidney transplant recipients |
| Q36436001 | Effects of 6-thioguanine and S6-methylthioguanine on transcription in vitro and in human cells |
| Q44983460 | Effects of light energy and reducing agents on C60-mediated photosensitizing reactions |
| Q55265769 | Effects of mTOR-Is on malignancy and survival following renal transplantation: A systematic review and meta-analysis of randomized trials with a minimum follow-up of 24 months. |
| Q53098481 | Effects of mammalian target of rapamycin inhibitors on cytokine production and differentiation in keratinocytes. |
| Q42516595 | Epidemiology of keratinocyte carcinomas after organ transplantation |
| Q40983397 | Exposure to moxifloxacin and cytomegalovirus replication is associated with skin squamous cell carcinoma development in lung transplant recipients. |
| Q39037391 | Formation and repair of oxidatively generated damage in cellular DNA. |
| Q35698913 | From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma |
| Q35128847 | Generation of reactive oxygen species by lethal attacks from competing microbes |
| Q48247468 | Growth rates of pulmonary metastases after liver transplantation for unresectable colorectal liver metastases |
| Q39843689 | Guanine sulphinate is a major stable product of photochemical oxidation of DNA 6-thioguanine by UVA irradiation |
| Q28540791 | Harmful effects of the azathioprine metabolite 6-mercaptopurine in vascular cells: induction of mineralization |
| Q38240647 | Human Beta-papillomavirus infection and keratinocyte carcinomas |
| Q34974648 | Human skin carcinoma arising from kidney transplant-derived tumor cells |
| Q35617246 | Identification of potentially cytotoxic lesions induced by UVA photoactivation of DNA 4-thiothymidine in human cells |
| Q39879692 | Immune effector cells produce lethal DNA damage in cells treated with a thiopurine |
| Q35050810 | Immune profiling and cancer post transplantation |
| Q38179468 | Immune-mediated inflammatory reactions and tumors as skin side effects of inflammatory bowel disease therapy |
| Q41645033 | Immunosuppressant-driven de novo malignant neoplasms after solid-organ transplant |
| Q35818080 | Immunosuppression and Multiple Primary Malignancies in Kidney-Transplanted Patients: A Single-Institute Study |
| Q38026406 | Immunosuppression-related lymphomas and cancers in IBD: how can they be prevented? |
| Q36830121 | Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review |
| Q37591675 | Immunosuppressive treatment after solid organ transplantation and risk of post-transplant cutaneous squamous cell carcinoma |
| Q35893844 | In vitro replication and thermodynamic studies of methylation and oxidation modifications of 6-thioguanine |
| Q35606909 | Incidence of Cancer in ANCA-Associated Vasculitis: A Meta-Analysis of Observational Studies |
| Q38413238 | Incidence of Malignancies in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Diagnosed Between 1991 and 2013. |
| Q36037651 | Incidence of malignancy after living kidney transplantation: a multicenter study from iran |
| Q27025406 | Incidence, risk factors and outcome of de novo tumors in liver transplant recipients focusing on alcoholic cirrhosis |
| Q26748580 | Incidence, risk factors and outcomes of de novo malignancies post liver transplantation |
| Q37624501 | Incidental adenocarcinoma in patients undergoing surgery for stricturing Crohn's disease. |
| Q39043418 | Increased non-melanoma skin cancer risk in young patients with inflammatory bowel disease on immunomodulatory therapy: a retrospective single-centre cohort study |
| Q33727211 | Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease |
| Q84156294 | Increased risk of squamous-cell carcinoma in simultaneous pancreas kidney transplant recipients compared with kidney transplant recipients |
| Q26745456 | Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatment |
| Q39773210 | Inflammatory bowel disease, cancer and medication: Cancer risk in the Dutch population-based IBDSL cohort |
| Q64099701 | Investigation into the use of histone deacetylase inhibitor MS-275 as a topical agent for the prevention and treatment of cutaneous squamous cell carcinoma in an SKH-1 hairless mouse model |
| Q90315913 | Keratinocyte Carcinomas: Current Concepts and Future Research Priorities |
| Q36782544 | Keratotic skin lesions and other risk factors are associated with skin cancer in organ-transplant recipients: a case-control study in The Netherlands, United Kingdom, Germany, France, and Italy |
| Q39539469 | Known and potential new risk factors for skin cancer in European populations: a multicentre case-control study |
| Q34070112 | LC-MS/MS coupled with stable isotope dilution method for the quantification of 6-thioguanine and S(6)-methylthioguanine in genomic DNA of human cancer cells treated with 6-thioguanine |
| Q49722515 | Light-Induced Covalent Buffer Adducts to Histidine in a Model Protein. |
| Q40940707 | Long-term CD4 lymphopenia is associated with accelerated decline of kidney allograft function |
| Q47739192 | Long-term Change in the Risk of Skin Cancer After Organ Transplantation: A Population-Based Nationwide Cohort Study |
| Q41771210 | MUTYH mediates the toxicity of combined DNA 6-thioguanine and UVA radiation |
| Q38010633 | Management of non-melanoma skin cancer in immunocompromised solid organ transplant recipients |
| Q42456451 | Management of non-melanoma skin cancer in solid organ transplant recipients |
| Q27320787 | Melanoma Risk and Survival among Organ Transplant Recipients. |
| Q38118880 | Milestones in photocarcinogenesis |
| Q37049512 | Molecular and cellular mechanisms of photocarcinogenesis |
| Q34573854 | Molecular profiling of cutaneous squamous cell carcinomas and actinic keratoses from organ transplant recipients. |
| Q30835452 | More epidermal p53 patches adjacent to skin carcinomas in renal transplant recipients than in immunocompetent patients: the role of azathioprine |
| Q37955182 | Multiple forms of DNA damage caused by UVA photoactivation of DNA 6-thioguanine |
| Q40450769 | Mutagenic and cytotoxic properties of 6-thioguanine, S6-methylthioguanine, and guanine-S6-sulfonic acid. |
| Q37358453 | Mutagenicity and potential carcinogenicity of thiopurine treatment in patients with inflammatory bowel disease |
| Q38969032 | Myasthenia gravis: recent advances in immunopathology and therapy |
| Q38210623 | Non-melanoma skin cancer is reduced after switch of immunosuppression to mTOR-inhibitors in organ transplant recipients |
| Q35633626 | Non-targeting siRNA induces NPGPx expression to cooperate with exoribonuclease XRN2 for releasing the stress |
| Q34975612 | Nonmelanoma skin cancer in inflammatory bowel disease |
| Q35680367 | Nrf2 Activation Protects against Solar-Simulated Ultraviolet Radiation in Mice and Humans |
| Q50519523 | Optical absorption and magnetic circular dichroism spectra of thiouracils: a quantum mechanical study in solution. |
| Q38228585 | Optimal management of skin cancer in immunosuppressed patients |
| Q35283173 | Oral azathioprine leads to higher incorporation of 6-thioguanine in DNA of skin than liver: the protective role of the Keap1/Nrf2/ARE pathway. |
| Q34609514 | Overall and cause-specific mortality in Crohn's disease: a meta-analysis of population-based studies |
| Q27863353 | Overexpression of selenoprotein H reduces Ht22 neuronal cell death after UVB irradiation by preventing superoxide formation |
| Q39042732 | Oxidatively-generated damage to DNA and proteins mediated by photosensitized UVA |
| Q46947476 | PDT as a cytotoxic agent and biological response modifier: Implications for cancer prevention and treatment in immunosuppressed and immunocompetent patients |
| Q36944052 | PTCH mutations in basal cell carcinomas from azathioprine-treated organ transplant recipients. |
| Q34713840 | Pathogenesis of nonmelanoma skin cancers in organ transplant recipients |
| Q34413976 | Pharmacogenetics of azathioprine in inflammatory bowel disease: a role for glutathione-S-transferase? |
| Q37965984 | Photodynamic therapy for actinic keratosis in organ transplant patients. |
| Q38176091 | Photosensitizing medications and photocarcinogenesis |
| Q36081139 | Pleomorphic malignant histiocytoma: a rare skin cancer in a patient on azathioprine for ulcerative colitis |
| Q57750146 | Polygenic risk score as a determinant of risk of non-melanoma skin cancer in a European-descent renal transplant cohort |
| Q37863680 | Post-transplant malignancy: reducing the risk in kidney transplant recipients |
| Q38611709 | Post-transplantation malignancies: here today, gone tomorrow? |
| Q21261410 | Posttransplantation malignancy in a patient presenting with weight loss and changed bowel habits: a case report |
| Q60921182 | Practical guidance for the management of inflammatory bowel disease in patients with cancer. Which treatment? |
| Q34984571 | Procarcinogenic effects of cyclosporine A are mediated through the activation of TAK1/TAB1 signaling pathway |
| Q37876951 | Proliferation signal inhibitors and post-transplant malignancies in heart transplantation: practical clinical management questions |
| Q45136999 | Protein oxidation and DNA repair inhibition by 6-thioguanine and UVA radiation. |
| Q26744266 | Protein oxidation, UVA and human DNA repair |
| Q35534821 | Quantification of Thiopurine/UVA-Induced Singlet Oxygen Production |
| Q37149792 | Reactive oxygen species generated by thiopurine/UVA cause irreparable transcription-blocking DNA lesions |
| Q40068682 | Reactive oxygen-mediated damage to a human DNA replication and repair protein |
| Q42795506 | Recurrent Non-melanoma Skin Cancer: Remission of Field Cancerization after Conversion from Calcineurin Inhibitor- to Proliferation Signal Inhibitor-based Immunosuppression in a Cardiac Transplant Recipient |
| Q42499557 | Regression of BCC following immunosuppression withdrawal in a renal transplant recipient |
| Q90045000 | Reinvigoration of diploid strawberry (Fragaria vesca) during adventitious shoot regeneration |
| Q88848697 | Response to 'The importance of immunosuppression as risk and prognostic factor for periorbital non-melanoma skin cancers' |
| Q26822029 | Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease |
| Q39014703 | Risk of Aggressive Skin Cancers After Kidney Retransplantation in Patients With Previous Posttransplant Cutaneous Squamous Cell Carcinomas: A Retrospective Study of 53 Cases |
| Q38725469 | Risk of Second Malignancies in Solid Organ Transplant Recipients Who Develop Keratinocyte Cancers. |
| Q90737442 | Risk of lip cancer after solid organ transplantation in the United States |
| Q45943688 | Risk of melanoma and non-melanoma skin cancer in ulcerative colitis patients treated with thiopurines: a nationwide retrospective cohort. |
| Q33786255 | Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease |
| Q35029320 | Risk of merkel cell carcinoma after solid organ transplantation |
| Q82948889 | Risk of non-melanoma skin cancer in autoimmune hepatitis |
| Q45478307 | Risk of non-melanoma skin cancer in myasthenia patients treated with azathioprine |
| Q35403714 | Roles of the immune system in skin cancer. |
| Q40521435 | Rose Bengal-photosensitized oxidation of 4-thiothymidine in aqueous medium: evidence for the reaction of the nucleoside with singlet state oxygen |
| Q51206994 | S1-Guidelines on UV phototherapy and photochemotherapy. |
| Q42470631 | Skin cancer evaluation in transplant patients: a physician opinion survey with recommendations |
| Q26822549 | Skin cancer in organ transplant recipients: effects of immunosuppressive medications on DNA repair |
| Q26851436 | Skin cancer in solid organ transplant recipients: are mTOR inhibitors a game changer? |
| Q37053236 | Skin cancer in transplant recipients, out of the woods. Scientific retreat of the ITSCC and SCOPE. |
| Q37687958 | Skin changes following organ transplantation: an interdisciplinary challenge |
| Q43855889 | Skin tumors in organ-transplant recipients |
| Q40257939 | Spectrum of Immune-Related Conditions Associated with Risk of Keratinocyte Cancers among Elderly Adults in the United States |
| Q42149278 | Stimulus-responsive liquids for encapsulation storage and controlled release of drugs from nano-shell capsules |
| Q91707032 | Synthesis of Chalcone Derivatives: Inducing Apoptosis of HepG2 Cells via Regulating Reactive Oxygen Species and Mitochondrial Pathway |
| Q64253571 | The Role of the Immune System in Cutaneous Squamous Cell Carcinoma |
| Q52985758 | The Triplet State of 6-thio-2'-deoxyguanosine: Intrinsic Properties and Reactivity Toward Molecular Oxygen. |
| Q90104340 | The frequency of photosensitizing drug dispensings in Austria and Germany: a correlation with their photosensitizing potential based on published literature |
| Q58756343 | The genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signature |
| Q36435796 | The indirect antioxidant sulforaphane protects against thiopurine-mediated photooxidative stress |
| Q40237944 | The janus face of immunosuppression - de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich |
| Q46934214 | The oncogene ATF3 is potentiated by cyclosporine A and ultraviolet light A. |
| Q46271884 | The pathogenesis of cutaneous squamous cell carcinoma in organ transplant recipients. |
| Q38883237 | The safety of treatment options for pediatric Crohn's disease |
| Q39171826 | The stress response resolution assay. I. Quantitative assessment of environmental agent/condition effects on cellular stress resolution outcomes in epithelium |
| Q36747429 | Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing |
| Q28079644 | Thiopurines and inflammatory bowel disease: Current evidence and a historical perspective |
| Q34728470 | Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancer |
| Q37087479 | Thiopurines related malignancies in inflammatory bowel disease: local experience in Granada, Spain |
| Q38443981 | Toxicity and response to thiopurines in patients with inflammatory bowel disease |
| Q37593739 | Translating translation into patient benefit for atopic eczema |
| Q38784067 | Treatment of moderate-to-severe atopic eczema in adults within the U.K.: results of a national survey of dermatologists. |
| Q36711033 | Treatment of post-transplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy. |
| Q44547715 | Tumor and transplantation |
| Q35680668 | Type VI Secretion System Transports Zn2+ to Combat Multiple Stresses and Host Immunity. |
| Q37921124 | UVA photosensitization of thiopurines and skin cancer in organ transplant recipients |
| Q64084989 | Understanding the burden of refractory myasthenia gravis |
| Q35677669 | Use of azathioprine for graft-vs-host disease is the major risk for development of secondary malignancies after haematopoietic stem cell transplantation: a nationwide population-based study |
| Q26750190 | Use of biologics and chemotherapy in patients with inflammatory bowel diseases and cancer |
| Q41481044 | Use of photodynamic therapy for treatment of actinic keratoses in organ transplant recipients. |
| Q33621267 | Use of thiopurines in inflammatory bowel disease: Safety issues |
| Q46397135 | Use of thiopurines in the treatment of inflammatory bowel disease is associated with an increased risk of non-melanoma skin cancer in an at-risk population: a cohort study |
| Q33383930 | Visible light regulates neurite outgrowth of nerve cells |
| Q37049515 | Waveband and dose dependency of sunlight-induced immunomodulation and cellular changes |
| Q33614146 | Whole-Exome Sequencing Validates a Preclinical Mouse Model for the Prevention and Treatment of Cutaneous Squamous Cell Carcinoma |
| Q54690358 | [Cutaneous squamous cell carcinoma]. |
| Q53301944 | [Immunosuppressive therapy after transplantation. Dermatologic relevance and pathomechanisms]. |
| Q53254939 | [Phototherapy and carcinogenesis]. |
| Q83004526 | [Primary and secondary prevention of skin cancer in organ transplant recipients] |
| Q91289588 | pH Controlled Intersystem Crossing and Singlet Oxygen Generation of 8-Azaadenine in Aqueous Solution |
Search more.